Loomis, Sayles & Company
AKRO icon

Loomis, Sayles & Company’s Akero Therapeutics AKRO Stock Holding History

Loomis, Sayles & Company’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$28.9M Buy
540,788
+51,850
+11% +$2.77M 0.04% 181
2025
Q1 		$19.8M Buy
+488,938
New +$19.8M 0.03% 237